Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
CRISPR Therapeutics Expands Research and Manufacturing Facilities
CRISPR Therapeutics signed a full-building lease in July of 2020 for a 263,500-sf facility in Boston's Seaport district. Breakthrough Properties is the developer for the project, which was designed by Payette to provide best-in-class laboratory environments for life science research. Both LEED Gold and Fitwel certification will be sought for the structure, which will offer multiple amenities including outdoor terraces and a fitness center.
Saint Louis University Opens Integrated Science & Engineering Building
Saint Louis University opened the $50 million Interdisciplinary Science & Engineering Building in August of 2020 in St. Louis. Designed by Hastings+Chivetta with Research Facilities Design (RFD) as laboratory design consultant, the three-story, 90,000-sf facility features a full-height atrium, 10,000 sf of research space, and an active learning classroom that can accommodate up to 210 students.
Lincoln Property Company Breaks Ground on Waltham Life Science Building
Lincoln Property Company broke ground in July of 2020 on a 140,000-sf life science building in Waltham, Mass. Designed by DiMella Shaffer in collaboration with AHA Consulting Engineers, the four-story structure will offer 35,000 sf of flexible and customizable office and laboratory space on each floor. A robust mechanical penthouse will support the installation of sophisticated infrastructure, and highly resilient energy and telecommunications services will be ensured by an onsite emergency power supply.
Cell and Gene Therapy Catapult Plans COVID-19 Vaccine Production Center
The Cell and Gene Therapy Catapult is planning to create the Manufacturing Innovation Centre in Braintree in the United Kingdom. Supported by £100 million in government funding, the project will enable mass production of a COVID-19 vaccine. An existing pharmaceutical plant has been purchased from Benchmark Holdings at a cost of £16 million. The structure's GMP infrastructure for antigen production, formulation, process development, and scale manufacturing will be repurposed and enhanced. Completion is expected in December of 2021.
Fermi National Accelerator Laboratory Plans Integrated Engineering Research Center
Fermi National Accelerator Laboratory is planning to construct the $86 million Integrated Engineering Research Center in Batavia, Ill. Designed by Perkins+Will with Arup as consulting engineer, the collaborative 80,000-sf structure will collocate engineers, technicians, and scientists at the core of Fermi's campus. Supporting advanced programs in particle physics, the flexible facility will provide reconfigurable labs, offices, design studios, and testing suites.